Clinical study offer

🧩 Paid Dementia Clinical Trials

Browse recruiting dementia clinical trials across the United States. Find eligibility information, locations and research opportunities near you.

Loading...
Active Studies
Dementia
Condition

Active Clinical Trials for Dementia

Showing live studies from ClinicalTrials.gov. Data refreshes daily.

Loading studies...

Disclaimer: This content is for educational purposes and is not medical advice. Always consult a qualified healthcare provider for medical guidance.

About Dementia

Dementia is a decline in cognitive function affecting memory, thinking, and daily activities beyond normal aging. Clinical trials investigate disease-modifying therapies, cognitive training interventions, and treatments for behavioral symptoms.

Common Symptoms

Memory loss, difficulty communicating, poor judgment, confusion, personality changes, trouble with complex tasks, repetition, wandering, loss of spatial awareness

Risk Factors

Age, family history, genetic factors (APOE-e4), cardiovascular risk factors, head injury, limited education, social isolation, hearing loss

Treatment Overview

Treatment includes cholinesterase inhibitors and memantine for symptom management, along with behavioral interventions and caregiver support. Clinical trials explore anti-amyloid and anti-tau therapies, neuroprotective agents, and lifestyle-based prevention approaches.

Why Participate?

Dementia clinical trials are essential for finding treatments that can slow cognitive decline and improve quality of life for millions affected by age-related cognitive impairment.

Related Conditions

States with Dementia Clinical Trials

Cities with Dementia Clinical Trials

Frequently Asked Questions About Dementia Clinical Trials

Dementia clinical trials test new medications and interventions to slow cognitive decline and manage behavioral symptoms. Studies include both pharmacological and lifestyle-based approaches to brain health.
Eligibility depends on dementia type and stage, cognitive assessment scores, and overall health. Some studies include people with early symptoms while others focus on prevention.
Compensation varies. Participants may receive $50-$200 per visit with cognitive assessments and travel reimbursement provided.
Yes, participants receive regular cognitive and medical monitoring. Caregiver support is often available and all trials follow strict safety protocols.